Want to see GB:TCF full AI Analyst Report?
Evgen Pharma (TCF) Income Statement
4 Followers
Evgen Pharma Income Statement
Last quarter (Q4 2025), Evgen Pharma's total revenue was £0.00. In Q4, Evgen Pharma's net income was £-2.22M. See Evgen Pharma’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| £ 0.00 | £ 0.00 | £ 396.00K | £ 442.00K | £ 0.00 | |
| £ -16.00K | £ -2.11M | £ 385.00K | £ 429.00K | £ -16.00K | |
| £ 3.67M | £ 12.00K | £ 3.94M | £ 5.50M | £ 3.17M | |
| Depreciation and Amortization | £ 16.00K | £ 69.00K | £ 11.00K | £ 13.00K | £ 16.00K |
| £ -3.67M | £ -2.06M | £ -3.55M | £ -4.99M | £ -3.15M | |
| £ -3.69M | £ -2.12M | £ -3.56M | £ -5.07M | £ -3.19M | |
| £ 117.00K | £ 39.00K | £ -6.00K | £ 98.00K | £ 22.00K | |
| £ -3.57M | £ -2.08M | £ -3.57M | £ -5.01M | £ -3.17M | |
| £ -3.53M | £ -1.94M | £ -3.14M | £ -4.04M | £ -2.73M | |
| Per Share Metrics | |||||
| Basic EPS | £ -0.00 | £ -0.00 | £ -0.01 | £ -0.01 | £ -0.01 |
| Diluted EPS | £ -0.00 | £ -0.00 | £ -0.01 | £ -0.01 | £ -0.01 |
| Weighted Average Shares Outstanding | 2.15B | 538.31M | 274.89M | 274.89M | 274.89M |
| Weighted Average Shares Outstanding (Diluted) | 2.15B | 538.31M | 274.89M | 274.89M | 274.89M |
Currency in GBP
